Manufacturer record

Stadmed Private Limited: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

9 batches manufactured by Stadmed Private Limited (Uttar Pradesh) were declared Not of Standard Quality between April 2019 and July 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

9 records linked to Stadmed Private Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
9Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Apr 2019 to Jul 2023

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

9
NSQ batches since 2019
4
Products affected
Microbial limits
Most common failure
Jul 2023
Latest alert

Flagged batches per year

2019 · 12021 · 52022 · 12023 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Paracin Plus Suspension (Ibuprofen and Paracetamol Suspension) KCC24A0 02A1AMfg 2023-04 · Exp 2025-03 Assay of Ibuprofen and ParacetmolAssay CDL KolkataCDSCO lab Jul 2023
Paracin Plus Suspension (Ibuprofen and Paracetamol Suspension) KCC24A0 01A1AMfg 2023-04 · Exp 2025-03 Assay of Ibuprofen and ParacetmolAssay CDL KolkataCDSCO lab Jul 2023
Diaset 1 (Glimepiride Tablets I.P. 1 mg) C22F81Mfg 2021-09 · Exp 2024-08 DissolutionDissolution CDTL MumbaiCDSCO lab Apr 2022
Disilox MPS (Aluminium, Magnesium and Simethicone Oral Suspension I.P.) C22C105Mfg 2021-06 · Exp 2024-05 Microbial contaminatio n in total aerobic viable count and presence of pathogens (E.coli.)Microbial limits CDTL MumbaiCDSCO lab Dec 2021
Disilox MPS (Aluminium, Magnesium and Simethicone Oral Suspension I.P.) C22E106Mfg 2021-08 · Exp 2024-07 Microbial contaminatio n in totalMicrobial limits CDTL MumbaiCDSCO lab Dec 2021
Disilox MPS (Aluminium, Magnesium and Simethicone Oral Suspension I.P.) C22E107Mfg 2021-08 · Exp 2024-07 Microbial contaminatio n in total aerobic viable count and presence of pathogens (E. coli.)Microbial limits CDTL MumbaiCDSCO lab Dec 2021
Ciprofloxacin Hydrochloride Tablets IP 500 mg C21C470Mfg 2020-06 · Exp 2023-05 DissolutionDissolution CDTL ChennaiCDSCO lab Sep 2021
Disilox MPS (Aluminium, Magnesium & Simethicone Oral Suspension I.P.) C20C92Mfg 2019-06 · Exp 2022-05 Microbial Contamination (Total Aerobic Viable Count)Microbial limits CDL KolkataCDSCO lab Jan 2021
DIASET 2 (Glimepiride Tablets I.P. 2 mg) L35C15Mfg 2018-06 · Exp 2021-05 DissolutionDissolution CDL KolkataCDSCO lab Apr 2019

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.